AS/Spondyloarthritis

sheila RHEUMarampa

4 years ago

Do you routinely request for HLA-B27 in young patients w/ IBP? @RheumNow #ACR20

Meral K. El Ramahi, MD MeralElRamahiMD

4 years ago

Do you take into account the location of bone marrow edema in the SI joint of a pt w/ inflammatory back pain when trying to determine if a pt has SpA? Check out Abst1535 at #ACR20 for more thoughts on this. @RheumNow @ElaineHusniMD

Eric Dein ejdein1

4 years ago

~1/3 early RA patients report unacceptable pain w/in one year of diagnosis. 69% have pain w/ low inflammation. No objective baseline measures predict unacceptable pain. #ACR20 @RheumNow Abs#1716 We need to start pain approaches at time of diagnosis for all

Eric Dein ejdein1

4 years ago

Pulmonary disease and glucocorticoid usage risk factors for RA medication changes in first 3 month of #COVID19. Pts with higher reported disease activity more likely to make Rx changes #ACR20 @RheumNow. Abst#L05.

David Liew drdavidliew

4 years ago

My axSpA patients often ask me whether whether it's the weight loss that matters, or just exercise. Some answers from @rheum_cat - BMI itself does matter in AS. Another one chalked up for the obesity-related inflammasome! #ACR20 ABST1883 @RheumNow https://t.co/oMOqA8ypTt

Delays in Diagnosis - Axial Spondyloarthritis: Dr Antoni Chan

4 years ago

Dr. Antoni Chan reviews abstracts #1303 and #1306 presented at the ACR 2020 annual meeting.

Axial Spondyloarthritis Agents: Dr Antoni Chan

4 years ago

Dr. Chan reviews several abstracts #1366, #1367 and #1364 at the 2020 ACR annual meeting.

Tight Control Tune: Third Verse, Same as the First? TICOSPA. Dr. Jeff Curtis

4 years ago

Dr. Jeff Curtis reviews abstract #1444 (results of the TICOSPA trial) at the 2020 ACR annual meeting.

Missing the Mark: AxSpa Treat to Target (TICOSPA Trial): Dr. Lianne Gensler

4 years ago

Dr. Lianne Gensler discusses abstract #1444 - the results of the TICOSPA trial - and its importance despite a negative outcome at the 2020 ACR annual meeting.